Public Health Agency of Canada, Ottawa, Ontario, Canada.
Osteoporos Int. 2011 May;22(5):1389-99. doi: 10.1007/s00198-010-1362-7. Epub 2010 Aug 21.
We assessed vitamin D status and its correlates in the population-based Canadian Multicentre Osteoporosis Study (CaMos). Results showed that serum 25-hydroxyvitamin D levels <75 nmol/L were common. Given Canada's high latitude, attention should be given to strategies for enhancing vitamin D status in the population.
Inadequate vitamin D has been implicated as a risk factor for several clinical disorders. We assessed, in a Canadian cohort, vitamin D status and its correlates, based on serum 25-hydroxyvitamin D [25(OH)D], the best functional indicator of vitamin D status.
We studied 577 men and 1,335 women 35+ years from seven cities across Canada in the randomly selected, population-based Canadian Multicentre Osteoporosis Study (CaMos). Participants completed a comprehensive questionnaire. Serum 25(OH)D was measured by immunoassay. Multivariate linear regression modeling assessed the association between 25(OH)D and determinants of vitamin D status.
Participants (2.3%) were deficient in 25(OH)D (<27.5 nmol/L); a further 18.1% exhibited 25(OH)D insufficiency (27.5-50 nmol/L). Levels <75 nmol/L were evident in 57.5% of men and 60.7% of women and rose to 73.5% in spring (men) and 77.5% in winter (women); 25(OH)D <50 nmol/L was ≤10% year round for those supplementing with ≥400 IU vitamin D/day but was 43.9% among those not supplementing in winter and spring. The strongest predictors of reduced 25(OH)D for both men and women were winter and spring season, BMI ≥30, non-white ethnicity, and lower vitamin D supplementation and its modification by fall and winter.
In this national Canadian cohort, vitamin D levels <75 nmol/L were common, particularly among non-white and obese individuals, and in winter and spring. Vitamin D intake through diet and supplementation and maintenance of normal weight are key modifiable factors for enhancing vitamin D status and thus potentially influencing susceptibility to common chronic diseases.
我们评估了基于人群的加拿大骨质疏松症多中心研究(CaMos)中维生素 D 状况及其相关因素。结果表明,血清 25-羟维生素 D 水平<75nmol/L 很常见。鉴于加拿大的高纬度,应关注提高人群维生素 D 状况的策略。
维生素 D 不足已被认为是多种临床疾病的危险因素。我们根据血清 25-羟维生素 D [25(OH)D]评估了加拿大队列中的维生素 D 状况及其相关因素,25(OH)D 是维生素 D 状况的最佳功能指标。
我们研究了来自加拿大七个城市的 577 名男性和 1335 名 35 岁以上的随机选择的人群为基础的加拿大骨质疏松症多中心研究(CaMos)的参与者。参与者完成了一份全面的问卷。血清 25(OH)D 通过免疫测定法测量。多元线性回归模型评估了 25(OH)D 与维生素 D 状况决定因素之间的关系。
参与者(2.3%)的 25(OH)D 缺乏(<27.5nmol/L);另有 18.1%的人存在 25(OH)D 不足(27.5-50nmol/L)。57.5%的男性和 60.7%的女性的水平<75nmol/L,在春季(男性)和冬季(女性)上升到 73.5%和 77.5%;在冬季和春季,每天补充≥400IU 维生素 D 的人群中,25(OH)D<50nmol/L 的比例≤10%,但不补充的人群中则为 43.9%。男性和女性 25(OH)D 减少的最强预测因素是冬季和春季、BMI≥30、非白色人种以及较低的维生素 D 补充及其与秋季和冬季的相互作用。
在这个全国性的加拿大队列中,维生素 D 水平<75nmol/L 很常见,尤其是在非白人和肥胖人群中,以及在冬季和春季。通过饮食和补充剂摄入维生素 D 并保持正常体重是增强维生素 D 状态的关键可改变因素,从而可能影响常见慢性疾病的易感性。